Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin.

× No keyword cloud information.

10 in total

1. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom.

Authors: K Shannon; P Stapleton; X Xiang; A Johnson; H Beattie; F El Bakri; B Cookson; G French
Journal: J Clin Microbiol Date: 1998-10 Impact factor: 5.948

2. Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media.

Authors: K Fonseca; J MacDougall; T L Pitt
Journal: J Clin Pathol Date: 1986-02 Impact factor: 3.411

3. Strategies for typing and properties of epidemic methicillin-resistant Staphylococcus aureus.

Authors: B Cookson; H Talsania; J Naidoo; I Phillips
Journal: Eur J Clin Microbiol Date: 1986-12 Impact factor: 3.267

Review 4. In vitro antibacterial effects of cephalosporins.

Authors: J D Williams; F Moosdeen
Journal: Drugs Date: 1987 Impact factor: 9.546

5. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.

Authors: A King; C Boothman; I Phillips
Journal: Eur J Clin Microbiol Infect Dis Date: 1990-09 Impact factor: 3.267

Review 6. Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors: I Phillips
Journal: Drugs Date: 1987 Impact factor: 9.546

7. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.

Authors: G L French; K P Shannon; N Simmons
Journal: J Clin Microbiol Date: 1996-02 Impact factor: 5.948

8. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.

Authors: A von Graevenitz; C Bucher
Journal: Infection Date: 1982 Sep-Oct Impact factor: 3.553

9. In vitro activity of cefpodoxime, a new oral cephalosporin, compared with that of nine other antimicrobial agents.

Authors: M Sheppard; A King; I Phillips
Journal: Eur J Clin Microbiol Infect Dis Date: 1991-07 Impact factor: 3.267

Review 10. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors: A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal: Drugs Date: 1983-03 Impact factor: 9.546

10 in total